Summary
- Current Price
- As of today, APGE price is $134.09, down -0.16% on
- Current Price All-Time High
- APGE price is currently -0.28% below its historical high of $134.46 set on
- Market Cap
- APGE current market cap is $10B, up +342.20% over the past 365 days
- Revenue
- APGE current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for APGE is on
Profile
| Metric | Value |
|---|---|
| Full Name | Apogee Therapeutics, Inc. |
| Ticker | NASDAQ: APGE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | apogeetherapeutics.com |
| Employees | 196 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $134.09 | |
| Price, 1D Change | -0.16% | |
| Market Cap | $10B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.96 | |
| Revenue | $0 | |
| Revenue, 1Y Change | 0.00% | |
| EPS | -$4.22 | |
| EPS, 1Y Change | -27.74% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$4.22 | |
| EPS Estimate | N/A | -$4.41 |
| EPS Est. Change | N/A | -4.68% |
| Revenue | $0.00 | |
| Revenue Estimate | N/A | $9.09M |
| Revenue Est. Change | N/A | - |
| Current Price | $134.09 | |
| Price Target | - | $135.00 |
| Price Tgt. Change | - | +0.68% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.09 | -$3.30 | -6.66% | |
| -$4.20 | -$4.22 | -0.39% | |
| -$4.41 | N/A | -4.68% | |
| -$5.19 | N/A | -23.08% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| $9.09M | N/A | - | |
| $12.50M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +250.47% | |
| Price, 3Y | +526.59% | |
| Market Cap, 1Y | +342.20% | |
| Market Cap, 3Y | +829.65% | |
| Revenue, 1Y | 0.00% | |
| Revenue, 3Y | 0.00% | |
| EPS, 1Y | -27.74% | |
| EPS, 3Y | -436.94% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $134.09 | |
| SMA 200 | $82.93 | |
| SMA 50 | $112.77 | |
| EMA 200 | $86.80 | |
| EMA 50 | $117.93 | |
| MACD | $5.09 | |
| Beta | 0.96 | |
| ATR | $1.21 | |
| 14-Day RSI | 78.55 | |
| 10-Day Volatility | 1.46% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$4.22 | |
| Gross Profit | -$1.42M | |
| - | ||
| Operating Income | -$285.60M | |
| - | ||
| Net Income | -$255.84M | |
| - | ||
| EBITDA | -$284.18M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.01 | |
| 26.57 | ||
| 26.57 | ||
| - | ||
| - | ||
| 180.98 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| - | ||
| 8.03 | ||
| -29.74 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $903.88M | |
| $730.19M | ||
| $937.13M | ||
| $741.36M | ||
| $33.25M | ||
| $27.91M | ||
| Total Debt | $8.85M | |
| $3.50M | ||
| $1.22M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $255.84M | ||
| $284.18M | ||
| $1.42M | ||
| $0.00 | ||
| $1.42M | ||
| $0.00 | ||
| $278.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$227.45M | ||
| -$179.57M | ||
| $396.49M | ||
| Capex | $5.15M | |
| -$232.60M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| TD Cowen | → | |
| Stifel | → | |
| Mizuho | → | |
| Guggenheim | → | |
| Wedbush | → | |
| UBS | → | |
| RBC Capital | → | |
| Deutsche Bank | → | |
| Citigroup | → | |
| Canaccord Genuity | → |
Analyst sentiment
Institutional ownership
Screeners with APGE
FAQ
- What is the ticker symbol for Apogee Therapeutics, Inc.?
- The ticker symbol for Apogee Therapeutics, Inc. is NASDAQ:APGE
- Does Apogee Therapeutics, Inc. pay dividends?
- No, Apogee Therapeutics, Inc. does not pay dividends
- What sector is Apogee Therapeutics, Inc. in?
- Apogee Therapeutics, Inc. is in the Healthcare sector
- What industry is Apogee Therapeutics, Inc. in?
- Apogee Therapeutics, Inc. is in the Biotechnology industry
- What country is Apogee Therapeutics, Inc. based in?
- Apogee Therapeutics, Inc. is headquartered in United States
- When did Apogee Therapeutics, Inc. go public?
- Apogee Therapeutics, Inc. initial public offering (IPO) was on July 14, 2023
- Is Apogee Therapeutics, Inc. in the S&P 500?
- No, Apogee Therapeutics, Inc. is not included in the S&P 500 index
- Is Apogee Therapeutics, Inc. in the NASDAQ 100?
- No, Apogee Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Apogee Therapeutics, Inc. in the Dow Jones?
- No, Apogee Therapeutics, Inc. is not included in the Dow Jones index
- When was Apogee Therapeutics, Inc. last earnings report?
- Apogee Therapeutics, Inc.'s most recent earnings report was on May 11, 2026
- When does Apogee Therapeutics, Inc. report earnings?
- The next expected earnings date for Apogee Therapeutics, Inc. is August 10, 2026
Data Sources & References
- APGE Official Website www.apogeetherapeutics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1974640/000197464026000002/0001974640-26-000002-index.htm
- APGE Profile on Yahoo Finance finance.yahoo.com/quote/APGE
- APGE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/apge